What Plasma Surgical does

Plasma Surgical is a private US-based medical device company founded in 2000 that designs, manufactures, and directly sells the PlasmaJet Surgery System, a capital-plus-consumables surgical platform based on proprietary pure-plasma energy technology. The system's console delivers gas and energy to a handpiece that produces a precise, rapidly dissipating pure plasma stream used to cut, dissect, vaporize, coagulate, and surface seal soft tissue in open and videoscopic procedures; the company markets two product variants, the PlasmaJet Ultra+ and the PlasmaJet V3+. The platform is positioned as the only surgical system using pure plasma, with no lateral thermal spread and low depth diffusion into ablated tissue — properties the company claims enable minimally invasive surgery and tissue preservation.

The company targets gynecologic surgeons and oncologists, general surgical oncologists, and their patients, with clinical emphasis on endometriosis surgery, ovarian endometrioma management, and ovarian cancer cytoreduction; enterprise customers include named NHS accounts such as the Royal Surrey NHS Foundation Trust, which has used the system for over a decade. Revenue is generated through direct enterprise field sales of consoles plus recurring handpiece and accessory consumables, with quote-based, multi-year procurement contracts to hospitals and surgical centers. Commercial presence spans the USA, 20+ European countries, and Australasia (Australia and New Zealand), with no disclosed parent company, venture backing, M&A activity, or AI/ML capabilities in the input data.

Name

Plasma Surgical

Legal name

Plasma Surgical

Website

https://plasmasurgical.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Plasma Surgical is a private US medical device company that designs and directly sells the PlasmaJet Surgery System, a proprietary pure-plasma energy platform used by gynecologic and surgical oncologists for soft-tissue cutting, dissection, vaporization, and coagulation across the USA, 20+ European countries, and Australasia.

Ownership category

akta.pro rank

Headquarters

HQ city

Roswell

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. PlasmaJet Surgical System Sales: Sale of PlasmaJet surgical systems including console and handpiece units to hospitals and surgical centers. The system is indicated for dissection, cutting, coagulation and removal of soft tissue by vaporization in open and videoscopic procedures.
2. Surgical Equipment Consumables: Sale of handpieces and related surgical accessories for the PlasmaJet system, providing recurring revenue from surgical facilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Plasma Surgical designs, manufactures, and sells the PlasmaJet Surgery System, a proprietary pure plasma energy surgical platform consisting of a console and handpiece. The system enables surgeons to cut, dissect, vaporize, coagulate, and surface seal soft tissue in open and videoscopic procedures. It is sold primarily to hospitals and surgical centers for use in gynecology, gynecologic oncology, endometriosis treatment, and general oncologic surgery, with supporting recurring revenue from handpieces and consumables.

Product overview

Plasma Surgical offers the PlasmaJet system, a surgical platform based on pure-plasma technology. The portfolio includes PlasmaJet Ultra+ and PlasmaJet V3+ as the core surgical tool variants, both comprising a console (which delivers gas and energy) and a handpiece (which releases precise plasma streams). These all-in-one surgical instruments use pure plasma energy to cut, dissect, vaporize, coagulate, and surface seal soft tissue during open and videoscopic surgical procedures.

Differentiator

Problem solved

Functional benefit

Brands

• PlasmaJet Ultra+: All-in-one surgical tool that uses Pure-Plasma to cut, dissect, vaporize, coagulate and surface seal tissue with control.
• PlasmaJet V3+

Products and services

• PlasmaJet Ultra+ All-in-one surgical tool that uses pure plasma to cut, dissect, vaporize, coagulate, and surface seal soft tissue with control, intended for use in open and videoscopic surgical procedures by gynecologic, oncologic, and general surgeons.
• PlasmaJet V3+ Surgical plasma system variant comprising a console and handpiece that produces a pure plasma stream for dissection, cutting, coagulation, and vaporization of soft tissue in open and videoscopic procedures.
• PlasmaJet System The full PlasmaJet platform consisting of a console that delivers gas and energy and a handpiece whose tip releases a precise, rapidly dissipating pure plasma stream for surgical applications.

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Erbe Elektromedizin: German specialist manufacturer of electrosurgical generators, argon plasma coagulation (APC) systems, and surgical energy devices — the closest direct competitor to PlasmaJet's plasma-based surgical technology. Strong in Europe with global distribution.
• Apyx Medical (formerly Bovie Medical): Pure-play energy device company whose Renuvion plasma/Helium-based technology competes in the same plasma-energy surgical niche as PlasmaJet. Similar scale and commercialization stage make it a direct strategic comparable.

Broad incumbents

• CONMED Corporation: Offers electrosurgical generators, smoke management, and advanced energy devices for general and gynecologic surgery, overlapping with PlasmaJet's core open and videoscopic soft-tissue energy applications across global markets.
• Medtronic: Global medical device leader whose Advanced Energy portfolio (including LigaSure and Valleylab electrosurgical generators) competes directly in the energy-based soft-tissue surgery category where PlasmaJet operates. Significantly broader portfolio, sales force, and installed base.
• Smith+Nephew: Global medtech with sports medicine, ENT, and advanced wound management franchises plus electrosurgical offerings, providing overlapping energy-based surgical capabilities to hospitals and ambulatory surgery centers similar to PlasmaJet's customer base.
• Ethicon (Johnson & Johnson): Surgical franchise of J&J offering Harmonic ultrasonic devices and ENSEAL tissue sealers — direct competitors in energy-based soft-tissue cutting, dissection, and coagulation, with much larger global sales coverage and hospital relationships.
• Stryker Corporation: Diversified surgical and medical device company with energy and surgical instrument lines used in gynecology, oncology, and minimally invasive procedures — adjacent competitive footprint to PlasmaJet with far larger R&D and commercial resources.
• Olympus Corporation: Markets Thunderbeat and other hybrid energy devices for laparoscopic and open surgery, overlapping directly with PlasmaJet's open and videoscopic soft-tissue energy applications. Broad endoscopic and surgical portfolio gives it scale advantages.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ThePlasmaJet
• LinkedInlinkedin.com/company/plasma-surgical-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasma Surgical